A Single-Ascending-Dose Study of RO5469754 in Healthy Volunteers

NCT01620931 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteer

Interventions

DRUG: Placebo
DRUG: RO5469754

Sponsor

Hoffmann-La Roche